JD Health International Inc. reported no change in either authorised or issued share capital for the month ended 31 May 2026. Authorised capital remained at 100.00 billion ordinary shares with a par value of USD 0.0000005 each, equivalent to USD 50,000 in total.

Issued shares stood unchanged at 3.21 billion, and the company held no treasury shares at month-end. The Hong Kong public-float requirement of at least 25 per cent was fully satisfied.

Share-based incentive activity was limited. The Pre-IPO ESOP still had 9.43 million outstanding options, with no grants, exercises, cancellations or lapses recorded during the month. The Post-IPO Share Option Scheme held no outstanding options but retains capacity for up to 312.71 million new shares. Under the Post-IPO Share Award Scheme, 15.37 million shares remain available for future awards; no new shares were issued or transferred in May.

The only notable movement was the repurchase of 15.95 million ordinary shares during the month. These shares, intended for cancellation, had not yet been cancelled as of 31 May 2026 and therefore are not reflected as a reduction in issued share capital.

No warrants, convertible securities or other equity-linked instruments were outstanding or exercised, and the company raised no funds through equity issuance during the reporting period.